Skip to main content

Table 2 Descriptive parameters of the kinetics of serum Neopterin and serum β2-microglobulin increments (N = 12)

From: Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

Parameter Neopterin β2-microglobulin
Rmax 8.0 ± 4.2 ng/mL 2.7 ± 1.4 μg/mL
T(Rmax) 48 ± 24 h 24 ± 24 h
λ effect 0.02 ± 0.01 h-1 0.02 ± 0.01 h-1
t1/2 effect 40.3 ± 12.9 h 37.6 ± 15.9 h
AUEC 661 ± 322 ng.h/mL 195 ± 117 μg.h/mL
MET 80.6 ± 17.4 h 74.8 ± 21.9 h
  1. Data are reported as mean ± standard deviation, except for T(Rmax) expressed as median ± quartile range.